How Are New Clinical Trials Transforming HER2 Positive Breast Cancer Treatment
Innovative clinical trials are revolutionizing treatment strategies for HER2-positive breast cancer, focusing on novel therapies and drug combinations. Key trials like HER2CLiMB-05 and DESTINY-Breast09 are exploring the efficacy of drugs like tucatinib and trastuzumab deruxtecan, while others investigate personalized approaches in therapy. These studies not only aim to improve efficacy and safety but also to […]
3 minute read